[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.87.119.171. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
October 4, 2000

Issues in Establishing Primary Stroke Centers

Author Affiliations
 

Stephen J.LurieMD, PhD, Senior EditorIndividualAuthorPhil B.FontanarosaMD, Executive Deputy EditorIndividualAuthor

JAMA. 2000;284(13):1647. doi:10.1001/jama.284.13.1647

To the Editor: Part of the rationale for primary stroke centers, which Dr Alberts and colleagues1 endorse, is to rapidly administer tPA to patients experiencing strokes. Alberts discloses that he has financial ties to Genentech Inc, which manufactures tPA.

It would be reassuring if the authors could definitively state that they have no other financial ties to any manufacturer of tPA. It would also be important to state that no expenses of the Brain Attack Coalition have been underwritten by any manufacturer of tPA.

First Page Preview View Large
First page PDF preview
First page PDF preview
×